A Phase I Study of Aflibercept Plus FOLFIRI (Irinotecan, 5-Fluorouracil, and Leucovorin) in Chinese Patients With Advanced Solid Malignancies

NCT01930552 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

20

Enrollment

INDUSTRY

Sponsor class

Conditions

Neoplasm Malignant

Interventions

DRUG: Aflibercept AVE0005
DRUG: Leucovorin
DRUG: Irinotecan
DRUG: 5-Fluorouracil

Sponsor

Sanofi

Collaborators

[object Object]